Limit by date

Multi-Million Investment in Thuringian Startups: Three InfectoGnostics Partners Secure Funding Rounds

applyo Jena, DeepEn, and Fluidect – three dynamic startups from the InfectoGnostics Research Campus Jena have successfully closed funding rounds to further develop their technologies and accelerate market entry. These companies exemplify the successful transfer of cutting-edge research into commercial applications.

applyo JENA: Expanding into International Markets with Series A Funding

Jena-based biotech startup applyo Jena has secured a successful Series A funding round led by Bosch Ventures and LBBW Venture Capital. With this investment, the company aims to expand its innovative lyophilized reagent solutions into international markets and explore new applications, particularly in the pharmaceutical industry.

applyo's technology enables the storage and transportation of sensitive reagents without continuous cooling, offering sustainable and scalable solutions for the diagnostics and life sciences sectors.

In collaboration with the InfectoGnostics Research Campus Jena and other partners, applyo will present its advancements at the AMR Conference on Novel Antimicrobials and AMR Diagnostics on February 25-26, 2025, in Basel, Switzerland.

DeepEn: Seed Investment and EU Grant for Holographic Endoscopy

DeepEn, a spin-off from the Leibniz Institute of Photonic Technology, has secured a seven-figure seed investment from bm|t, MBG Thüringen, and Sparkasse Jena-Saale-Holzland. The startup specializes in holographic endoscopy and will use the funding to further develop its ultra-thin fiber-optic microscopy instruments, unlocking new possibilities in neuroscience and biomedical research.

Additionally, DeepEn has received €2.5 million in funding from the EIC Transition Program to advance its technology in the NEUROGATE project, in collaboration with international partners.

Fluidect: FTI Thüringen Grant for Innovative Biosensor Technology

MedTech startup FluIDect has been awarded FTI Thüringen technology funding to advance its Fluorescent Resonator Signature (FRS) technology. This groundbreaking biosensor technology is designed for rapid antibiotic resistance diagnostics, particularly in detecting carbapenemase-producing bacteria, contributing to the fight against antimicrobial resistance (AMR).

These successful funding rounds highlight the innovative strength of the InfectoGnostics Research Campus Jena and reaffirm Jena’s position as a leading hub for cutting-edge research and technology commercialization.